Pancreatic Cancer Research

ResearcherThe University of Texas at AustinActive in the last 2 years

Erxi Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1680-3639; OpenAlex author ID A5070309078; NIH RePORTER profile ID 8226751. Sources: OpenAlex.

Their work

Papers
36 (first author 0, last author 15)
Trials
0
Grants
1
Labs led
2
Collaborators
69
Papers, trials and grants by year

2011: 5 papers · 2012: 4 papers · 2013: 5 papers · 2014: 6 papers · 2015: 5 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 36

  1. Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Co-author DOI 10.1016/j.biopha.2022.112713↗
  2. Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment. Last author DOI 10.3389/fonc.2022.923982↗
  3. Sonic hedgehog signaling pathway promotes pancreatic cancer pain via nerve growth factor. Co-author DOI 10.1136/rapm-2019-100991↗
  4. Cav-1 Ablation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Growth through Nrf2-Induced shh Signaling. Co-author DOI 10.1155/2020/1868764↗
  5. NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2020.01038↗
  6. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Co-author DOI 10.1111/cpr.12514↗
  7. Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling. Co-author DOI 10.3892/ijo.2018.4604↗
  8. Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells. Co-author DOI 10.1002/jcb.27266↗
  9. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2016.10.019↗
  10. β2-adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α. Co-author DOI 10.18632/oncotarget.5677↗
  11. Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway. Co-author DOI 10.18632/oncotarget.7776↗
  12. Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer. Co-author DOI 10.1080/15384047.2015.1040952↗
  13. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Co-author DOI 10.18632/oncotarget.2686↗
  14. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer. Co-author DOI 10.18632/oncotarget.3069↗
  15. Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis. Co-author DOI 10.18632/oncotarget.3663↗
  16. Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer. Co-author DOI 10.18632/oncotarget.5045↗
  17. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Co-author DOI 10.1016/j.canlet.2014.02.003↗
  18. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Co-author DOI 10.1155/2014/546353↗
  19. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-3426↗
  20. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signa… Co-author DOI 10.1186/1471-2407-14-686↗
  21. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. Last author DOI 10.2174/1568009614666140331231658↗
  22. The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer. Last author DOI 10.2174/1568009614666140402105101↗
  23. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells. Last author DOI 10.1158/1541-7786.mcr-12-0609↗
  24. Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Last author DOI 10.1186/1476-4598-12-66↗
  25. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells. Last author DOI 10.2174/09298673113209990249↗
  26. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Last author DOI 10.2174/09298673113209990251↗
  27. CA 19-9 and pancreatic cancer. Co-author PMID 23596673↗
  28. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathw… Co-author DOI 10.1016/j.canlet.2012.02.035↗
  29. Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer. Last author DOI 10.2174/13816128112092395↗
  30. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Last author DOI 10.2174/13816128112092404↗
  31. Advances in biomarker research for pancreatic cancer. Last author DOI 10.2174/13816128112092439↗
  32. Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-1α under normoxic condition. Last author DOI 10.1016/j.canlet.2011.01.017↗
  33. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. Last author DOI 10.1016/j.ejphar.2011.04.055↗
  34. β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway. Last author DOI 10.1186/1476-4598-10-146↗
  35. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. Last author DOI 10.1371/journal.pone.0017385↗
  36. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. Last author DOI 10.1371/journal.pone.0027074↗

Grants 1

  1. Biostatistics and Bioinformatics Core Facility P20GM109024↗

Closest collaborators

The 25 strongest of 69 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 35 shared papers, 2011–2022 · strength 1.89
  2. Wanxing Duan · 24 shared papers, 2012–2022 · strength 1.27
  3. Jiguang Ma · 22 shared papers, 2013–2022 · strength 1.24
  4. Qinhong Xu · 23 shared papers, 2011–2020 · strength 0.99
  5. Xuqi Li · 18 shared papers, 2012–2020 · strength 0.82
  6. Weikun Qian · 7 shared papers, 2018–2022 · strength 0.76
  7. Zheng Wang · 13 shared papers, 2011–2022 · strength 0.72
  8. Jianjun Lei · 16 shared papers, 2012–2020 · strength 0.71
  9. Zheng Wu · 11 shared papers, 2013–2022 · strength 0.68
  10. Katie M. Reindl · 2 shared papers, 1 shared grant, 2014–2026 · strength 0.54
  11. Liang Han · 11 shared papers, 2011–2020 · strength 0.52
  12. Sanku Mallik · 1 shared paper, 1 shared grant, 2012–2026 · strength 0.50
  13. Sathish Venkatachalem · 1 shared grant, 2026 · strength 0.46
  14. Jiha Kim · 1 shared grant, 2026 · strength 0.46
  15. Megan Orr · 1 shared grant, 2026 · strength 0.46
  16. Mohiuddin Quadir · 1 shared grant, 2026 · strength 0.46
  17. Ang Guo · 1 shared grant, 2026 · strength 0.46
  18. Mark T Hamann · 1 shared grant, 2026 · strength 0.46
  19. Roberto Gomes · 1 shared grant, 2026 · strength 0.46
  20. Jagdish Singh · 1 shared grant, 2026 · strength 0.46
  21. Estelle Leclerc · 1 shared grant, 2026 · strength 0.46
  22. John Curlee Wilkinson · 1 shared grant, 2026 · strength 0.46
  23. Elisabetta Liverani · 1 shared grant, 2026 · strength 0.46
  24. Bin Guo · 1 shared grant, 2026 · strength 0.46
  25. Yongki Choi · 1 shared grant, 2026 · strength 0.46

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.